J. H. Lee

J. H. Lee, J. Cheong, Y. Min, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic Role of Serum Lactate Dehydrogenase Beyond Initial Diagnosis: A Retrospective Analysis of Patients with Diffuse Large B Cell Lymphoma

Junshik Hong, Jinny Park, E. Cho, 2013, Acta Haematologica.

Clinical characteristics and outcomes of primary bone lymphoma in Korea

J. H. Lee, S. Y. Kim, H. Kang, 2012, The Korean journal of hematology.

Usefulness of 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Patients with High-Grade Non-Hodgkin’s Lymphoma

Junshik Hong, Jinny Park, J. H. Lee, 2012, Nuclear Medicine and Molecular Imaging.

Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia

Junshik Hong, Jinny Park, J. H. Lee, 2013, International Journal of Hematology.

Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II tria

J. H. Lee, Kihyun Kim, D. S. Lee, 2012, Annals of Hematology.

Nilotinib Combined With Multi-Agent Chemotherapy For Adult Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Final Results Of Prospective Multicenter Phase 2 Study

Jinny Park, J. H. Lee, Young-Uk Cho, 2013 .

N-ras Mutation Detection by Pyrosequencing in Adult Patients with Acute Myeloid Leukemia at a Single Institution

Junshik Hong, Jinny Park, J. H. Lee, 2013, Annals of laboratory medicine.

Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes

Jinny Park, J. H. Lee, J. Cheong, 2013, British journal of haematology.

The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2017, Oncotarget.

Heparin-Induced Thrombocytopenia (HIT) in Patients with Acute Coronary Syndrome: Incidence and Clinical Feature, Retrospective Study

S. Park, E. Cho, D. Shin, 2005 .

Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial

S. Park, E. Cho, D. Shin, 2005, BMC Cancer.

Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF

J. H. Lee, J. Cheong, Jin Seok Kim, 2016, Leukemia & lymphoma.

Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma

J. H. Lee, Kihyun Kim, Je-Jung Lee, 2022, Annals of Hematology.

Changes in quality of life during palliative chemotherapy for solid cancer

S. Park, E. Cho, D. Shin, 2005, Supportive Care in Cancer.

Prognostic significance of PCR-based molecular staging in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy

Junshik Hong, Jinny Park, J. H. Lee, 2017, Leukemia & lymphoma.

Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)

Junshik Hong, J. H. Lee, S. Kim, 2016, Oncotarget.

Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis

Junshik Hong, Jinny Park, E. Cho, 2010, The Korean journal of hematology.

Screening PCR Versus Sanger Sequencing: Detection of CALR Mutations in Patients With Thrombocytosis

Junshik Hong, Jinny Park, J. H. Lee, 2016, Annals of laboratory medicine.

Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myeloma.

M. Dimopoulos, J. H. Lee, R. Hájek, 2019, Blood.

Randomized phase 3 study of carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible , NDMM patients Running title : KMP vs VMP for newly diagnosed multiple myeloma

M. Dimopoulos, J. H. Lee, P. Moreau, 2019 .

Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)

J. H. Lee, J. Lee, Sung-Soo Yoon, 2020, Therapeutic advances in hematology.

High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study.

M. Ahn, E. Cho, J. H. Lee, 2003, Journal of Korean medical science.

High Dose Therapy Followed by Autologous Peripheral Blood Stem Cell Transplantation as a First Line Treatment for Multiple Myeloma

M. Ahn, E. Cho, J. H. Lee, 2003 .

Clinical features and treatment outcome of primary systemic light‐chain amyloidosis in Korea: Results of multicenter analysis

J. H. Lee, Kihyun Kim, S. Kim, 2013, American journal of hematology.

Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma

S. Park, E. Cho, D. Shin, 2006, Cancer.

A pilot study of cisplatin, irinotecan, leucovorin and 5-fluorouracil (PILF) combination chemotherapy for advanced gastric cancer.

S. Park, E. Cho, D. Shin, 2006, Cancer research and treatment : official journal of Korean Cancer Association.

Bone marrow involvement is predictive of infusion-related reaction during rituximab administration in patients with B cell lymphoma

Junshik Hong, Jinny Park, E. Cho, 2013, Supportive Care in Cancer.

Two Cases of Interstitial Pneumonitis Caused by Rituximab Therapy

D. Shin, J. H. Lee, S. Bang, 2006, The Korean journal of internal medicine.

A randomized trial of anemia correction with two different hemoglobin targets in the first-line chemotherapy of advanced gastric cancer

S. Park, E. Cho, D. Shin, 2008, Cancer Chemotherapy and Pharmacology.

Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.

J. Ahn, J. H. Lee, Y. Min, 2010, Japanese journal of clinical oncology.

Prognostic Value of AML1/ETO Fusion Transcripts in Patients with Acute Myelogenous Leukemia

E. Cho, D. Shin, J. H. Lee, 2003, The Korean journal of internal medicine.

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results

J. H. Lee, M. Kurosawa, J. Kuroda, 2022, Haematologica.

Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS working party.

J. H. Lee, J. Cheong, Hyeoung-Joon Kim, 2017, Oncotarget.

Intravenous busulfan and melphalan versus high-dose melphalan as a conditioning regimen for early autologous stem cell transplantation in patients with multiple myeloma: a propensity score-matched analysis

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2020, Leukemia & lymphoma.

Tumor Necrosis Factor-α Enhances DMSO-Induced Differentiation of HL-60 Cells through Activation of ERK/MAPK Pathway.

S. Park, Jinny Park, D. Shin, 2007 .

Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy

Junshik Hong, Jinny Park, E. Cho, 2014, Cancer science.

Role of induction and consolidation chemotherapy in elderly acute myeloid leukemia patients

Jinny Park, J. H. Lee, J. Cheong, 2014, International Journal of Hematology.

Vascular Complications in Patients with Essential Thrombocythemia

S. Park, E. Cho, D. Shin, 2006 .

Outcome of Adult Severe or Very Severe Aplastic Anemia Treated with Immunosuppressive Therapy Compared with Bone Marrow Transplantation: Multicenter Trial

M. Ahn, J. H. Lee, Junghye Choi, 2003, International journal of hematology.

A complex, four-way variant t(15;17) in acute promyelocytic leukemia.

J. H. Lee, Y. Seo, J. Ahn, 2006, Cancer genetics and cytogenetics.

Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.

Jinny Park, E. Cho, D. Shin, 2010, Leukemia research.

Brief report: Clinical experiences after emergency use of daratumumab monotherapy for relapsed or refractory multiple myeloma in real practice

J. H. Lee, Kihyun Kim, Jin Seok Kim, 2018, Japanese journal of clinical oncology.

Low-dose abdominopelvic computed tomography in patients with lymphoma: An image quality and radiation dose reduction study

Jinny Park, J. H. Lee, K. Yoo, 2022, PloS one.

Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.

S. Park, Jinny Park, E. Cho, 2008, International journal of radiation oncology, biology, physics.

Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine

J. H. Lee, Y. Min, Sung-Soo Yoon, 2009, Annals of Hematology.

A Patient with Common Variable Immunodeficiency Followed by Severe Aplastic Anemia Successfully Treated with Allogenic Stem Cell Transplantation

Junshik Hong, J. H. Lee, M. Y. Baek, 2015 .

Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan

Junshik Hong, J. H. Lee, 2013, Annals of Hematology.

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.

J. H. Lee, J. Cheong, Y. Min, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical characteristics and treatment outcome of acute myeloid leukemia in elderly patients in Korea: a retrospective analysis

Guk Jin Lee, Jinny Park, J. H. Lee, 2014, Blood research.

Phase 3 Study (CLARION) of Carfilzomib, Melphalan, Prednisone (KMP) v Bortezomib, Melphalan, Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM)

M. Dimopoulos, J. Miguel, J. H. Lee, 2017 .

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial

Junshik Hong, J. H. Lee, J. Lee, 2017, Blood research.

Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment.

M. Beksac, M. Dimopoulos, H. Einsele, 2016, Blood.

Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.

Junshik Hong, Jinny Park, E. Cho, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial

J. H. Lee, W. Crist, M. Qi, 2019, Annals of Hematology.

Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients

J. H. Lee, V. Voelter, Kihyun Kim, 2013, Annals of Hematology.

Epstein-Barr Virus-Positivity in Tumor has no Correlation with the Clinical Outcomes of Patients with Angioimmunoblastic T-cell Lymphoma

D. Shin, J. H. Lee, W. Kim, 2008, The Korean journal of internal medicine.

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for advanced gastric carcinoma.

E. Cho, D. Shin, J. H. Lee, 2002, Journal of Korean medical science.

Optimal timing of treatment at relapse after autologous stem cell transplantation in patients with multiple myeloma: a study of the Korean Multiple Myeloma Working Party (KMM-1909)

J. H. Lee, Kihyun Kim, Je-Jung Lee, 2022, Bone Marrow Transplantation.

Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia

M. Ahn, E. Cho, J. H. Lee, 2022, The Korean journal of internal medicine.

Long-term follow-up results of cytarabine-contain-ing chemotherapy for acute promyelocytic leukemia Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia

M. Ahn, E. Cho, J. H. Lee, 2022 .

Prognostic implications of the immunophenotype in biphenotypic acute leukemia

J. H. Lee, J. Cheong, Y. Min, 2006, Leukemia & lymphoma.

Molecular cytogenetic analysis of Korean patients with Waldenström macroglobulinemia.

Sun-Hee Kim, J. H. Lee, Kihyun Kim, 2010, Cancer genetics and cytogenetics.

High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma

Yeon-Hee Park, E. Cho, J. H. Lee, 2005, Leukemia & lymphoma.

Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma

Keunchil Park, Sarah Park, J. H. Lee, 2007, Leukemia & lymphoma.

Reactivation of Hepatitis B Virus Following Systemic Chemotherapy for Malignant Lymphoma

Junshik Hong, J. H. Lee, O. Kwon, 2013 .

Recent advances in multiple myeloma: a Korean perspective

Junshik Hong, J. H. Lee, 2016, The Korean journal of internal medicine.

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

B. Barlogie, G. Morgan, J. Miguel, 2018, Blood Cancer Journal.

Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial.

M. Dimopoulos, H. Einsele, S. Lonial, 2016, The Lancet. Haematology.

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study.

Keunchil Park, Jeeyun Lee, Yeon-Hee Park, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)

J. H. Lee, I. Hwang, Sukjoong Oh, 2011, BMC Cancer.

A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma

J. H. Lee, Y. Won, S. Kim, 2020, Annals of Hematology.

Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

S. Park, Young Saing Kim, Jinny Park, 2011, Medical oncology.

Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma.

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2008, Clinical lymphoma & myeloma.

Pharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study

D. Esseltine, Huyuan Yang, A. Hui, 2015, Journal of Hematology & Oncology.

Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy.

Junshik Hong, Jinny Park, E. Cho, 2015, Journal of geriatric oncology.

Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors

Ha Yeon Lee, Young Saing Kim, Junshik Hong, 2014, Investigational New Drugs.

A randomized double-blind placebo-controlled study of low-dose intravenous Lorazepam to reduce procedural pain during bone marrow aspiration and biopsy.

S. Park, E. Cho, D. Shin, 2008, Pain medicine.

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer

Young Saing Kim, Junshik Hong, Jinny Park, 2016, The Korean journal of internal medicine.

Management of multiple myeloma in Asia: resource-stratified guidelines.

J. H. Lee, W. Chng, T. Chou, 2013, The Lancet. Oncology.

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy

Young Saing Kim, Junshik Hong, Jinny Park, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Plerixafor use for peripheral blood stem cell mobilization in Korea

J. H. Lee, Sung-Soo Yoon, S. Kim, 2013, Blood research.

Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study

S. Park, E. Cho, D. Shin, 2006, The Korean journal of internal medicine.

Comparison of Microvessel Density Before and after Peripheral Blood Stem Cell Transplantation in Multiple Myeloma Patients and Its Clinical Implications: Multicenter Trial

Sung-Bae Kim, Q. Park, M. Ahn, 2002, International journal of hematology.

Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia

J. H. Lee, Á. Illés, M. Šimkovič, 2021, Blood.

A phase I/II study of bortezomib plus CHOP every 2 weeks (CHOP-14) in patients with advanced-stage diffuse large B-cell lymphomas

Jinny Park, J. H. Lee, Dae-Ho Lee, 2012, The Korean journal of hematology.

Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop

J. H. Lee, Kihyun Kim, W. Chng, 2018, Leukemia & lymphoma.

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma

Junshik Hong, J. H. Lee, S. Kim, 2017, Oncotarget.

A t(11;14)(p13;q11.2) in myelofibrosis following polycythemia vera.

J. H. Lee, Y. Seo, J. Jeong, 2016, Cancer genetics.

CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy

Junshik Hong, Jinny Park, E. Cho, 2012, Annals of Hematology.

Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study

J. H. Lee, S. Kim, Jin Seok Kim, 2019, Cancer communications.

Anemia is the strongest prognostic factor for outcomes of 5-fluorouracil-based first-line chemotherapy in patients with advanced gastric cancer

Joon-Oh Park, Keunchil Park, Jeeyun Lee, 2005, Cancer Chemotherapy and Pharmacology.

Osteonecrosis of the Jaw in Multiple Myeloma Patients: Incidence and Characteristics in Korean Patients.

J. H. Lee, S. Kim, M. K. Kim, 2009 .

Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

S. Park, E. Cho, D. Shin, 2005, BMC Cancer.

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): a joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network.

J. H. Lee, G. Teoh, Kihyun Kim, 2013, Leukemia research.

Matched‐pair analysis comparing the outcomes of primary breast and nodal diffuse large B‐cell lymphoma in patients treated with rituximab plus chemotherapy

J. H. Lee, Dae-Ho Lee, S. Kim, 2012, International journal of cancer.

Recurrent and metastatic trichilemmal carcinoma of the skin over the thigh: a case report.

S. Ha, Jinny Park, E. Cho, 2010, Cancer research and treatment : official journal of Korean Cancer Association.

Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.

J. Oh, S. Park, E. Cho, 2005, Japanese journal of clinical oncology.

Salvage chemotherapy with irinotecan and cisplatin in patients with metastatic gastric cancer failing both 5-fluorouracil and taxanes

S. Park, D. Shin, J. H. Lee, 2005, Anti-cancer drugs.

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial

M. Dimopoulos, J. H. Lee, M. Mohty, 2018, Leukemia.

Cyclophosphamide, Bortezomib, and Dexamethasone Consolidation in Patients with Multiple Myeloma after Stem Cell Transplantation: The KMM130 Study

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2022, Cancer research and treatment.

Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults

Junshik Hong, J. H. Lee, K. Yoo, 2020, PloS one.

A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

S. Park, E. Cho, D. Shin, 2005, Oncology.

Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2010, Annals of Hematology.

Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study

J. H. Lee, M. Kwon, Kihyun Kim, 2014, Annals of Hematology.

New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy.

J. H. Lee, Kihyun Kim, C. Suh, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries

J. H. Lee, Kihyun Kim, W. Chng, 2019, Annals of Hematology.

Clinical Features of Waldenstrom Macroglobulinemia in Korea

S. Park, E. Cho, D. Shin, 2004, The Korean journal of internal medicine.

A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2017, Oncotarget.

Continuous treatment with lenalidomide and low‐dose dexamethasone in transplant‐ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial

J. H. Lee, Zhi-xiang Shen, Kihyun Kim, 2017, British journal of haematology.

Epidemiological Change of Multiple Myeloma in Korea

J. H. Lee, S. Bang, 2006 .

Phase II trial of weekly docetaxel and gemcitabine for previously untreated, advanced non-small cell lung cancer.

S. Park, Junshik Hong, Jinny Park, 2008, Lung cancer.

A Successful Planned Pregnancy and Delivery with Eculizumab Maintenance in a Woman with Paroxysmal Nocturnal Hemoglobinuria

J. H. Lee, A. J. Kim, E. Cho, 2016 .

Acute Myeloid Leukemia with Persistent Marrow Aplasia after Chemotherapy Treated with Reduced-Intensity Allogeneic Stem Cell Transplantation

Junshik Hong, Jinny Park, J. H. Lee, 2014 .

Cytarabine and Idarubicin Induction Chemotherapy in Patients with Acute Myelogenous Leukemia

E. Cho, D. Shin, J. H. Lee, 2001 .

Panobinostat plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma who received prior bortezomib and IMiDs: A predefined subgroup analysis of PANORAMA 1.

M. Dimopoulos, H. Einsele, S. Lonial, 2015 .

Characterization of the Incidence and Management of Gastrointestinal Toxicity in the Phase 3 Panorama 1 Study of Panobinostat Plus Bortezomib and Dexamethasone Versus Placebo Plus Bortezomib and Dexamethasone in Patients with Relapsed or Relapsed and Refractory Multiple Myeloma

M. Dimopoulos, H. Einsele, S. Lonial, 2014 .

Evaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy

Junshik Hong, Jinny Park, E. Cho, 2011, Leukemia & lymphoma.

Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.

Sung-Soo Yoon, Hyun Jung Min, Dong Soon Lee, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Outcome and Predictive Factors in the Response to Splenectomy in Elderly Patients with Primary Immune Thrombocytopenia: A Multicenter Retrospective Study

Guk Jin Lee, Junshik Hong, Jinny Park, 2016, Acta Haematologica.

A Multi-Center, Open Label Study Evaluating the Efficacy of Iron Chelation Therapy with Deferasirox in Transfusional Iron Overload Patients with Myelodysplastic Syndromes or Aplastic Anemia Using Quantitative R2 MRI

J. H. Lee, J. Cheong, Y. Min, 2008 .

Early Response to Bortezomib Combined Chemotherapy Can Help Predict Survival in Patients with Multiple Myeloma Who Are Ineligible for Stem Cell Transplantation

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2013, Journal of Korean medical science.

Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil

S. Park, E. Cho, D. Shin, 2006, Anti-cancer drugs.

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

S. Park, E. Cho, D. Shin, 2006, BMC Cancer.

Safety and efficacy of nilotinib in adult patients with chronic myeloid leukemia: a post-marketing surveillance study in Korea

Jinny Park, J. H. Lee, J. Cheong, 2022, Blood research.

Clinical predictors of long-term survival in newly diagnosed transplant eligible multiple myeloma — an IMWG Research Project

B. Barlogie, G. Morgan, J. Miguel, 2018, Blood Cancer Journal.

Validation of the revised diagnostic criteria for primary plasma cell leukemia by the Korean Multiple Myeloma Working Party

J. H. Lee, Kihyun Kim, S. Yoon, 2022, Blood Cancer Journal.

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

Young Saing Kim, Junshik Hong, Jinny Park, 2015, Cancer research and treatment : official journal of Korean Cancer Association.

Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study

S. Park, Young Saing Kim, Junshik Hong, 2008, Anti-cancer drugs.

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)

J. H. Lee, Shaji K. Kumar, Kihyun Kim, 2020, Leukemia.

Panorama 1: A randomized, double-blind, phase 3 study of panobinostat or placebo plus bortezomib and dexamethasone in relapsed or relapsed and refractory multiple myeloma.

M. Dimopoulos, H. Einsele, S. Lonial, 2014 .

Prognostic Value of Metabolic Tumor Volume Estimated by 18 F-FDG Positron Emission Tomography/Computed Tomography in Patients with Diffuse Large B-Cell Lymphoma of Stage II or III Disease

Kyung Hoon Hwang, Junshik Hong, Jinny Park, 2014, Nuclear Medicine and Molecular Imaging.

Baseline renal function as a prognostic indicator in patients with newly diagnosed diffuse large B-cell lymphoma

Junshik Hong, Jinny Park, E. Cho, 2016, Blood research.

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)

J. H. Lee, Kihyun Kim, Sukjoong Oh, 2010, Annals of Hematology.

Deacetylase inhibitors: an advance in myeloma therapy?

H. Einsele, S. Lonial, J. Laubach, 2017, Expert review of hematology.

Updated Results from ASPIRE and ENDEAVOR, Randomized, Open-Label, Multicenter Phase 3 Studies of Carfilzomib in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

D. Siegel, J. H. Lee, R. Hájek, 2017 .

First-Line Chemotherapy with Irinotecan plus Capecitabine for Advanced Colorectal Cancer

J. Oh, S. Park, E. Cho, 2004, Oncology.

Cervical Lymphadenopathy Mimicking Angioimmunoblastic T-Cell Lymphoma after Dapsone-Induced Hypersensitivity Syndrome

Junshik Hong, Jinny Park, J. H. Lee, 2012, Korean journal of pathology.

Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone

J. H. Lee, Kihyun Kim, Sung-Soo Yoon, 2020, International Journal of Hematology.

Update on a Phase III Study of Panobinostat with Bortezomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: PANORAMA 1,

M. Dimopoulos, H. Einsele, S. Lonial, 2011 .

Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials

M. Dimopoulos, J. H. Lee, S. Iida, 2019, International Journal of Hematology.

Clinical Profile of Multiple Myeloma in Asia - an Asian Myeloma Network (AMN) Study

J. H. Lee, G. Teoh, Kihyun Kim, 2012 .

Low-dose capecitabine plus trastuzumab as first-line treatment in patients 75 years of age or older with HER2-positive advanced gastric cancer: a pilot study

Young Saing Kim, Junshik Hong, Jinny Park, 2015, Cancer Chemotherapy and Pharmacology.

Rusfertide (PTG-300) Induction Therapy Rapidly Achieves Hematocrit Control in Polycythemia Vera Patients without the Need for Therapeutic Phlebotomy

J. H. Lee, R. Hoffman, Y. Ginzburg, 2021, Blood.

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

H. Goldschmidt, G. Morgan, A. Palumbo, 2012, Leukemia.

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project

H. Goldschmidt, B. Barlogie, G. Morgan, 2013, Leukemia.

Phase I study of 3-weekly combination chemotherapy using epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer

Jinny Park, E. Cho, D. Shin, 2012, Cancer Chemotherapy and Pharmacology.

Gemcitabine versus gemcitabine combined with cisplatin treatment locally advanced or metastatic pancreatic cancer: a retrospective analysis.

J. H. Lee, Hyo-jin Kim, S. Oh, 2008, Cancer research and treatment : official journal of Korean Cancer Association.

Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (VELCADE®, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with VELCADE for Newly Diagnosed Multiple Myeloma: Interim Results of Phase II Trial.

J. H. Lee, D. S. Lee, Sung-Soo Yoon, 2007 .

Management of multiple myeloma in Asia: resource-stratified guidelines.

J. H. Lee, W. Chng, T. Chou, 2013, The Lancet. Oncology.

Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer

S. Park, Junshik Hong, Jinny Park, 2010 .

A Phase II Study of Paclitaxel and Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer.

J. Ahn, E. Cho, D. Shin, 2003, Cancer research and treatment : official journal of Korean Cancer Association.

Successful Treatment with Low-dose Rituximab in a Patient with Plasma Exchange-refractory Idiopathic Thrombotic Thrombocytopenic Purpura

Junshik Hong, Jinny Park, J. H. Lee, 2015 .